Economic burden of osteoporotic fractures in Austria

  • Hans Peter Dimai1Email author,

    Affiliated with

    • Kurt Redlich2,

      Affiliated with

      • Monika Peretz3,

        Affiliated with

        • Fredrik Borgström4, 5,

          Affiliated with

          • Uwe Siebert6 and

            Affiliated with

            • Jörg Mahlich7

              Affiliated with

              Health Economics Review20122:12

              DOI: 10.1186/2191-1991-2-12

              Received: 9 March 2012

              Accepted: 27 June 2012

              Published: 27 June 2012

              Abstract

              Objective

              Osteoporotic fractures impose a huge economic burden on society. Though several cost of illness studies from other countries exist, no equivalent study has been conducted in Austria. Our study aims at assessing costs resulting from osteoporotic fractures in Austria in the year 2008 from a societal perspective.

              Methods

              We took both direct and indirect costs into consideration. Direct costs encompass medical costs such as expenses for pharmaceuticals, inpatient and outpatient medical care costs, as well as other medical services (e.g., occupational therapies). Non-medical direct costs include transportation costs and medical devices (e.g., wheel chairs or crutches). Indirect costs refer to costs of productivity losses due to absence of work. Moreover, we included costs for early retirement and opportunity costs of informal care provided by family members. For our analysis, we combined data of official statistics, expert estimates as well as unique patient surveys that are currently conducted in the course of an international osteoporotic fracture study in Austria.

              Results

              For the year 2008, the total annual financial burden incurred by osteoporotic fractures in Austria amounted to approx. €685.2 million, the largest fraction of which was due to the opportunity cost of family care (30.2%), followed by costs for hospitalization (26.6%).

              Conclusions

              The financial burden of osteoporotic fractures in Austria is substantial. Our findings may have implications for future economic analyses, and also support health care authorities in their decision making.

              Keywords

              Burden of illness Costs of illness Osteoporosis Austria

              Background

              Osteoporosis is defined as a „systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue with a consequent increase in bone fragility and susceptibility to fracture” [1]. The average lifetime risk in a 50 year old person to experience an osteoporotic fracture has been estimated at 40-50% for women and at 13-22% for men [2]. Accordingly, it has been estimated that in the year 2000 some 9 million osteoporotic fractures have occurred worldwide, including 1.6 million hip fractures, 1.7 million forearm fractures, and 1.4 million clinical (symptomatic) vertebral fractures [3]. These major osteoporotic fractures have been shown to be associated with significant morbidity, and hip and vertebral fractures have been shown to be associated even with excess mortality [4]. Furthermore, the combined annual costs of all osteoporotic fractures have been estimated to be $20 billion in the United States and €30 billion in the European Union, indicating that in addition to morbidity and mortality, osteoporotic fractures are also associated with a significant financial burden to the society [5].

              Assessment of the national financial burden of osteoporosis is usually undertaken by means of cost-of-illness studies [6], and several of such have been conducted throughout a number of countries worldwide, particularly in countries of the so called Western World [712]. However, the majority of these studies have primarily focused on costs occasioned by hip fractures, since national data on the epidemiology of this type of fracture are more likely to be readily accessible than data from any other type of osteoporotic fracture [3, 4, 6]. Furthermore, due to differences in healthcare systems, approaches utilized to estimate the number of fractures nationwide, methods of pricing and reimbursement, types and qualities of data as well as computations, results of cost-of-illness studies among different countries can hardly be compared [6]. However, irrespective of such uncertainties, it has been widely accepted that osteoporotic fractures impose a huge economic burden worldwide, with a trend towards further increases [6].

              Austria counted some 8.3 million inhabitants at the beginning of 2008. Similar to many other European countries, Austria’s age pyramid at the beginning of the twenty-first century shows a narrow base due to a reduction in birth-rates, whereas the percentage of the senior population 50 years of age and older, is increasing. Within the elderly Austrian population, the number of women clearly exceeds the number of men which is due not only to the higher life expectancy of women, but also to the large number of men who died in World War II.

              The incidence of osteoporotic fractures in the Austrian population has been estimated to be among the highest worldwide [13]. For example, in 2008 the total number of hip fractures in the population 50 years and above was 15,615, with an age-standardized incidence of hip fractures for the female population of 605 per 100.000, and an age-standardized incidence of hip fractures in the according male population of 261 per 100.000 [13]. Consequently, it has been hypothesized that the financial burden of osteoporotic fractures in Austria must be substantial.

              The aim of the present study was to estimate the financial burden of osteoporotic fractures in the Austrian population, including fractures of the hip, vertebrae, distal forearm, humerus, and ribs.

              Methods

              Direct and indirect costs

              To estimate the financial burden, both direct and indirect costs related to osteoporotic fractures have been considered, except costs for rehabilitation. Direct costs in general encompass medical as well as non-medical costs directly related to the causative disease. Accordingly, we included costs for pharmacotherapy, hospital and nursing home, as well as costs for (follow-up) radiographs, wheel chairs, crutches, transport to outpatient settings etc. In contrast, indirect costs, sometimes also referred to as productivity costs, are a measure of present and/or future productivity losses caused by a disease. Indirect costs were calculated according to the human capital approach [14]. Hence, we included productivity loss due to absence from work as well as costs for early retirement and costs of informal (unpaid) care provided by family members and/or other persons. We decided to draw on the human capital approach rather than on the friction-cost method because the former is grounded in neoclassical economic theory while the latter is not [15]. Moreover, Austria’s unemployment rate in 2008 was among the lowest in Europe. This fact served as an additional argument to not employ the friction cost approach in our study. Only in case of labour market imperfections and high unemployment the friction cost approach might be considered as a feasible alternative.

              Source and quantity of costs following fracture

              Source and quantity of costs following the first year after fracture have been obtained from the Austrian branch of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS). The ICUROS is an ongoing international study supported by the International Osteoporosis Foundation (IOF) which aims at assessing the consequences of osteoporotic fractures in terms of costs and health related quality of life (QOL) in a standardized form, making results comparable among the different participating countries worldwide [data unpublished, http://​www.​medscinet.​com/​icuros/​project.​aspx]. To assess sources and quantities of costs for the prevailing study, an interim analysis of the Austrian study arm of the ICUROS was performed. Data were extracted from a total of 916 patients who had finished phase II of the study, i.e. who had at least one follow-up interview within the first year after the fracture. Of these patients, 488 had a hip fracture, 158 had a clinical vertebral fracture, 140 had distal forearm fracture, and 122 had a fracture of the humerus. Information on following parameters was obtained: Number of outpatient visits at the primary care level and/or hospital, number of home visits, number of phone counselling, use and dosage of drugs, number and type of community services and other services (e.g. nursing), information on working situation, type of employment (also part or full-time), number of sick days, informal care, information on investments directly or indirectly caused by fracture and its consequences (wheelchair, walking aids, modifications to house/apartment, special utensils for personal hygiene etc.).

              Depending on the source of costs, costs themselves where then obtained from institutions and services which most likely would have readily accessible the according information.

              Number of patients with osteoporotic fractures

              The number of patients with osteoporotic fractures was calculated for the entire Austrian population. The following types of fracture were included: hip fracture, humeral fracture, clinical (symptomatic) vertebral fracture, distal forearm fracture, and rib fracture. Since most but not all of the fractures may have been due to osteoporosis per se, specific weighting factors have been applied [11].

              Hip fractures

              The number of patients with hip fractures in Austria in 2008 was obtained from the Austrian Hospital Discharge Register (AHDR) for the entire population. As one hundred percent of people who sustain a hip fracture are admitted to hospitals, the number obtained from the AHDR is equivalent to the total number of patients who sustained a hip fracture in 2008. To correct for possible multiple registrations (within a year after admission) for the same diagnosis, a correction factor (0.9) has been applied. These data have been published recently [13].

              Humeral fractures

              The number of patients with humeral fractures admitted to hospitals in Austria in 2008 has been drawn from the AHDR. In contrast to patients who sustain a fracture of the hip, only a part of those who sustain a humeral fracture are admitted to hospitals. The proportion of patients who have been treated in an outpatient setting was assessed by extracting databases from seven large Trauma Units in Austria who covered about 20% of all humeral fractures that occurred in 2008 nationwide. Based on the data obtained from these Trauma Units, it has been estimated that the proportion of humeral fracture patients who have been admitted to hospitals (and hence captured by the AHDR) is 57%. An according correction factor was applied.

              Clinical vertebral fractures

              The number of patients with clinical vertebral fractures who have been admitted to hospitals in Austria in 2008 was derived from the AHDR. However, since not all patients with clinical vertebral fractures are admitted to hospitals, this number would reflect only part of the total number of patients. According to data derived from a recently published Swedish study, it was estimated that the number of patients with clinical vertebral fractures admitted to hospitals account for approximately 10% of all female patients with clinical vertebral fractures, and 15% of all male patients nationwide [16]. To estimate the total number of Austrian patients who sustained a clinical vertebral fracture, an according correction factor was applied.

              Forearm fractures

              The number of patients with forearm fractures who have been admitted to hospitals in Austria in 2008 was derived from the AHDR. Again, this number would reflect only part of the total number of patients who had sustained a forearm fracture, since many of these patients may be treated in an outpatient setting. Several studies have indicated that in general only approximately 20% of patients with distal forearm fractures are admitted to hospitals and treated in an inpatient setting, e.g. for the purpose of operative intervention [1719]. To estimate the total number of Austrian patients who sustained a forearm fracture, the according correction factor was applied.

              Rib fractures

              The number of patients with rib fractures who have been admitted to hospitals in 2008 in Austria was derived from the AHDR. Again, this number would reflect only part of the total number of patients who had sustained a rib fracture that came to clinical attention [20]. In a Finnish population it has been estimated that only about 10% of all rib fractures after minimal trauma would be admitted to hospitals [21]. To estimate the total number of Austrian patients with low trauma rib fractures, the according correction factor was applied.

              Costs of hospitalization

              Data on the average duration of stay in hospital per fracture type (i.e. hip, clinical vertebral, humerus, forearm, ribs) was obtained from the ICUROS, and/or provided by Statistics Austria. To estimate the total number of days of stay in hospital, the number of days of stay in hospitals per fracture type was multiplied by the number of patients who had sustained an according fracture under consideration of correction factors where applicable (see above), and results obtained from the different fracture types were then summarized.

              Data on costs per day of stay in hospital were provided by the Austrian Federal Ministry of Health. In average, in 2008 the cost of one day spent in an orthopaedic or trauma department of an Austrian Hospital was € 592 (including medications, nutrition etc.). This value was then multiplied by the total calculated hospital days of stay which have been caused by osteoporotic fractures.

              Costs of outpatient treatment

              Costs incurred through consultations of practicing and/or hospital employed specialists (e.g. orthopaedists) were calculated using data provided by the Central Association of Austrian Social Security Institutions. In average, costs for consultation of an orthopaedist in a hospital outpatient clinic were € 53.55 per consultation, and costs for consultation of an orthopaedist in the primary care setting were € 73.10 per consultation. These costs were then multiplied by the according number of consultations.

              Other medical and non-medical costs

              Number of radiographs, physical therapies and transportation as consequences of a fracture were obtained from the ICUROS database. Unit costs for radiographs, bone mineral density measurement (Dual x-ray Absorptiometry [DXA]) and physical therapy were provided by the Central Association of Austrian Social Security Institutions. Average unit cost of BMD-measurement (lumbar spine and hip) was estimated at € 35.00. Average unit cost of a radiograph was estimated at € 80.40, and the average unit cost of a standard physical therapy was estimated at € 30.00. Information on costs of non-emergency transportation was provided by a common Austrian Ambulance Service (Samariterbund). Mean cost per transportation was estimated at € 57.00. Unit cost for wheelchairs, wheeled walkers, crutches, ramps, cranes etc. were obtained through information provided by the according retail stores.

              Costs of pharmacotherapy

              Costs of pharmacotherapy were calculated based on the estimated number of incident osteoporotic fractures in Austria in 2008. However, since data from the Austrian study arm of the ICUROS indicates that only about 22% of patients with recent osteoporotic fracture would receive adequate osteoporosis treatment (data unpublished), estimation of costs of pharmacotherapy only took into account this proportion of patients. Furthermore, to further improve accuracy of estimation, we also considered the proportional distribution of osteoporosis drugs as derived from the ICUROS database. For estimation of costs incurred by analgesics, calcium and vitamin D, again data from the ICUROS were extracted which indicated that ~37% of patients following an osteoporotic fracture would receive analgesic therapy, and 40% would receive calcium and vitamin D. Drug prices were based on the 2008 version of the Austrian EKO (Erstattungskodex) [22].

              Costs of nursing and informal care

              Number of hours of nursing care and informal care as a consequence of osteoporotic fracture was obtained from the Austrian ICUROS database. Information on costs of nursing was provided by Statistics Austria, and the average cost of one hour of nursing was estimated at € 30. Information on number of hours of informal (unpaid) care provided by family members or other persons as a consequence of osteoporotic fracture was obtained from the Austrian ICUROS database. Cost of one hour of informal care was estimated at € 27.50, reflecting the average hourly wage of an Austrian employee [23].

              Costs of absenteeism

              Data regarding number and costs of sick-days due to osteoporotic fractures in the Austrian population were provided by Statistics Austria and the Austrian Pension Insurance Authority. In total, 3.490 men and 2.336 women had been on sick-leave due to such conditions in 2008. The average number of sick-days in these patients was 16.3 in men, and 18.9 in women. To estimate the costs of absenteeism, the mean annual gross salary per capita of Austrian employees was divided by 220 working days, and this number was then multiplied by the average number of osteoporotic-fracture associated sick-days. However, it should be considered that the costs estimated as described above, would rather underestimate the true costs, as wages alone would not include for example loss of profit or the employer’s contribution to the Austrian Social Security institutions. Therefore, to estimate the total loss of added value incurred through absenteeism, data from the official Input–output Table (IOT) were extracted. Data were provided by Statistics Austria. By means of this analysis, information on so called second round effects was obtained. Second round effects typically occur due to reduced productivity in one company or institution (e.g. caused by absenteeism of employees), with the consequence of decreasing output in supplying companies or institutions [24].

              Costs of early retirement

              According to data provided by the Federal Ministry of Labour, Social Affairs and Consumer Protection, as well as Statistics Austria, a total of 338.462 Austrians were registered as in early retirement due to disability (also referred to as disability pension) in 2008 [25], and 25.146 cases of early retirement have been newly registered throughout the year 2008. The average annual cost of early retirement per capita in 2008 was €13.395. Musculoskeletal and connective tissue diseases have been the underlying cause in 6.989 cases, of whom 0.338% was due to osteoporosis-related conditions [25]. Accordingly, the total number of disability pension cases due to osteoporosis-related conditions in 2008, was estimated at approximately 1.444. To calculate the total costs of early retirement due to osteoporosis-related conditions, the estimated number of cases was multiplied with the average annual costs per capita to come up with an estimated amount of € 19.3 million.

              Results

              The total cost of osteoporotic fractures in Austria from a societal perspective is € 685.6 million (Table 1). The two biggest cost drivers are the opportunity costs of family care and the cost of hospitalization. The cost of absenteeism in early retirement is rather low which reflects the fact that most patients suffering from an osteoporotic fracture have already left the labour market before the fracture has occurred.
              Table 1

              Direct, indirect, and total costs

                

              Costs (in € Mio)

              Propotion

              Direct costs

              Inpatient

              182.5

              26.6%

               

              Outpatient

              39.7

              5.8%

               

              Pharmacotherapy

              17.7

              2.6%

               

              Other medical and non-medical services

              67.6

              9.9%

               

              Nursing care

              67.0

              9.8%

               

              Special aids and equipment (e.g. crutches, wheel-chairs etc.)

              4.4

              0.6%

              Indirect costs

              Costs of absenteeism

              40.1

              5.8%

               

              - foregone wages

              −13.3

              −1.9%

               

              - loss of added value (e.g. profit, social insurance contributions etc.)

              −26.7

              −3.9%

               

              Early retirement

              19.3

              2.8%

               

              Family care

              207.3

              30.2%

              TOTAL

               

              685.6

              100%

              Number of fractures

              In 2008, an estimated total of 119,911 patients with incident osteoporosis-related fractures were treated in Austria (Table 2). 14,871 patients had sustained a hip fracture (12%), 23,934 (20%) a forearm fracture, 9,573 (8%) a humeral fracture, 39,028 (33%) a clinical vertebral fracture, and 32,505 (27%) a rib fracture. For lack of relevant data, morphometric vertebral fractures were not included in our study. Overall, 91,067 cases (76%) were first treated in an outpatient setting, and 28,844 cases (24%) in an inpatient setting.
              Table 2

              Number of fractures, number and costs of bed days, visits, medical and non-medical services

               

              Hip

              Forearm

              Humerus

              Clinical vertebral

              Rib

              Total

              m

              f

              m

              f

              m

              f

              f

              m

              f

              m

              Fractures

              Cases primarily treated in an inpatient setting

              3,415

              11,456

              878

              3,111

              770

              2,711

              1,193

              2,355

              1,590

              1,365

              28,844

              Cases primarily treated in an outpatient setting

              0

              0

              4,390

              15,555

              1,348

              4,744

              11,930

              23,550

              15,900

              13,650

              91,067

              Cases treated

              3,415

              11,456

              5,268

              18,666

              2,118

              7,455

              13,123

              25,905

              17,490

              15,015

              119,911

              Bed days

              Mean bed days per case

              16.6

              14.8

              3.7

              4.9

              5.21

              71

              5.21

              71

              5.21

              71

              7,7

              Total bed days

              56,689

              169,549

              3,249

              15,244

              4,004

              18,977

              6,202

              16,482

              8,268

              9,555

              308,219

              Costs total (€)2

              33,559,888

              100,373,008

              1,923,408

              9,024,448

              2,370,368

              11,234,384

              3,671,584

              9,757,344

              4,894,659

              5,656,560

              182,465,648

              Visits

              Mean number of visits to private practice offices

              1.67

              2.57

              0.33

              0.85

              0.53

              1.82

              2.20

              2.87

              2.20

              2.87

              1.79

              Total number of visits to private practice offices

              5,703

              29,442

              1,738

              15,866

              1,123

              13,568

              28,871

              74,347

              38,478

              43,093

              252,229

              Costs of visits to private practice offices (€)3

              416,889.3

              2,152,210.2

              127,047.8

              1,159,804.6

              82,091.3

              991,820.8

              2,110,470.1

              5,434,765.7

              2,812,741.8

              3,150,098.3

              18,437,939.9

              Mean number of visits to hospital outpatient clinics

              1.59

              1.27

              5.83

              5.15

              1.47

              1.71

              2.40

              1.71

              2.40

              1.71

              2,52

              Total number of visits to hospital outpatient clinics

              5,430

              14,549

              30,712

              96,130

              3,113

              12,748

              31,495

              44,298

              41,976

              25,676

              306,127

              Costs of visits to hospital outpatient clinics (€)4

              290,776.5

              779,098.95

              1,644,627.6

              5,147,761.5

              166,701.15

              682,655.4

              1,686,557.25

              2,372,157.9

              2,247,814.8

              1,374,949.8

              16,393,100.85

              Other medical and non-medical services

              Physical therapy (mean number of sessions per case)

              15.88

              14.03

              4.17

              13.09

              25.13

              19.98

              8.45

              8.22

              8.45

              8.22

              12.56

              Physical therapy (total number of sessions)

              54,230

              160,728

              21,968

              244,338

              53,225

              148,951

              110,889

              212,939

              147,791

              123,423

              1,278,482

              Costs of physical therapy (€)5

              1,626,900

              4,821,840

              659,040

              7,330,140

              1,596,750

              4,468,530

              3,326,670

              6,388,170

              4,433,730

              3,702,690

              38,354,460

              X-rays b (mean number per case)

              2.18

              2.,17

              3.5

              4.2

              1.33

              2.08

              2.5

              1.96

              2.5

              1.96

              2.43

              X-rays (total number)

              7,445

              24,860

              18,438

              78,397

              2,817

              15,506

              32,808

              50,774

              43,725

              29,429

              304,199

              Costs of X-rays (€)6

              598,578

              1,998,744

              1,482,415

              6,303,118

              226,486.8

              1,246,682.4

              2,637,763

              4,082,229

              3,515,490

              2,366,091

              24,457,599

              BMD Measurement7

              1,059

              3,551

              1,633

              5,787

              657

              2,311

              4,068

              8,030

              5,422

              4,655

              37,173

              Cost of BMD measurement (€)8

              37,065

              124,285

              57,155

              202,545

              22,995

              80,885

              142,380

              281,050

              189,770

              162,925

              1,301,055

              Transportation (mean number of units per case)

              0.73

              0.78

              ---

              0.89

              ---

              0.1

              0.55

              0.37

              0.55

              0.37

              0.43

              Transportation (total number of units)

              2,493

              8,936

              ---

              16,613

              ---

              746

              7,218

              9,585

              9,620

              5,556

              60,767

              Cost of transportation (€)9

              142,101

              509,352

              ---

              946,941

              ---

              42,522

              411,426

              546,345

              548,340

              316,692

              3,463,719

              1 mean values for ICD-10 codes S10-S51, S53-S71, S73-S81.

              2 Cost per bed day = € 592.

              3 Cost per visit to private practice office (specialist) = € 73.10.

              4 Cost per visit to hospital outpatient clinics (speacialist) = € 53.55.

              5 Cost per session of physical therapy = € 30.

              6 Cost per unit (i.e. X-ray) = € 80.40.

              7 In average, 31% of Austrian patients received BMD measurment within first year after fracture (ICUROS-Austria).

              8 Cost per BMD measurement (spine and hip).

              9 Average cost per unit (i.e. per ride, as invoiced by a typical Ambulance service) = € 57.00.

              Bed days

              Mean bed days per fracture type was 15.7 for hip fracture, 4.3 for forearm fracture, and 6.1 for humeral, clinical vertebral, and rib fractures (Table 2). The estimated total number of bed days for all fractures was 308,219. Inpatient costs were € 182.4 million, accounting for about 45% of direct costs, and 27% of total costs, respectively.

              Number of visits

              The total number of visits (not including the primary visit following fracture) to private practice offices and hospital outpatient clinics for all fractures was 252,229 and 306,127, respectively (Table 2). Mean number of visits to private practice offices and hospital outpatient clinics for all fractures was 1.7 and 2.5, respectively. Total costs of visits to private practice offices were € 18,375,371.6, and total costs of visits to hospital outpatient clinics were € 16,393,100.85, accounting for 5.8% of overall cost.

              Other medical and non-medical services

              214,958 physical therapy sessions have been utilized following hip fracture, 266,306 following forearm fracture, 202,176 following humeral fracture, 323,828 following clinical vertebral fracture, and 271,214 following rib fracture (Table 2). In total, 1,278,482 physical therapy sessions have been utilized throughout 2008 as a direct consequence of osteoporotic fractures. Total costs of all physical therapy sessions due to osteoporotic fractures were € 38.4 million, representing 5,6% of overall cost.

              An estimated 32,305 x-rays have been taken following hip fracture, 96.835 x-rays following forearm fracture, 18,323 x-rays following humeral fracture, 83,582 x-rays following clinical vertebral fracture, and 73,154 x-rays following rib fracture (Table 2). The estimated total number of x-rays as a consequence of osteoporotic fractures was 304,199. Total costs of all x-rays taken as a consequence of osteoporotic fractures were € 24.5 million, accounting for 3.6% of overall cost. It should be noted though that for lack of data, follow-up MRT’s or CT’s have not been included in our study, making it very likely that true costs have rather been higher than shown in this study.

              The number of transportation services required as a consequence of fracture was 11,429 for hip fracture, 16,613 for forearm fracture, 746 for humeral fracture, 16,803 for clinical vertebral fracture, and 15,176 for rib fracture (Table 2). In total, 60,766 units of transportation services have been utilized. Total costs of transportation services utilized as a consequence of osteoporotic fractures were € 3.5 million, accounting for 0.5% of overall cost.

              Pharmacotherapy

              A total of 22.4% of patients received adequate osteoporosis-specific treatment, which is a very low share from a medical point of view. Patients were treated with either alendronate (12%), risedronate (3.6%), ibandronate (3.6%), zoledronate (1.4%), parathyroid hormone (0.6%; including both teriparatide and 1–84 PTH), Raloxifene (0.4%), strontium ranelate (0.4%), or calcitonin nasal-spray (0.4%) (Table 3). Proportional cost of analgesic treatment was estimated at € 3,354,145, and costs of calcium and vitamin D treatment (without patients treated with alendronate or risedronate) at € 2,185,350. Overall, estimated cost of pharmacotherapy was € 17,920,047, accounting for 2.7% of total costs.
              Table 3

              Costs of pharmacotherapy

              Drug

              Brand Name(Austria)

              % patients with osteoporotic fracture (n = 119.911)

              Total number of patients treated

              Annual cost of treatment per capita3

              Total costs

              Alendronate

              Fosamax 10 mg®

              2.4% 1

              2,878

              321.0

              923,838

               

              Fosamax 70 mg®

              6.7%1

              8,034

              213.0

              1,711,242

               

              Generic Alendronate 70 mg (e.g. Alendronstad®)

              2.9% 1

              3,477

              205.2

              713,480

                

              {Total:12.0%}

                 

              Ibandronate

              Bonviva 3 mg®

              3.6%2

              4,316

              456.4

              1,969,822

              Risedronate

              Actonel 5 mg®

              0.5%2

              600

              438.6

              263,160

               

              Actonel 35 mg®

              3.1%2

              3,717

              490.2

              1,821,330

                

              {Total: 3.6%}

                 

              Zoledronate

              Aclasta 5 mg®

              1.4%

              1,679

              303.1

              508,905

              Raloxifene

              Evista 60 mg®

              0.4%

              480

              438.6

              210,528

              Strontium Ranelate

              Protelos 2 g®

              0.4%

              480

              570.6

              273,888

              Parathyroid-hormone

              Forsteo®/Preotact®

              0.6%

              720

              4,867.64

              3,504,672

              Calcitonin (nasal-spray)

              Calcitonin Novartis Nasal Spray®

              0.4%

              480

              639.0

              306,720

              Total

               

              22.4%

              26,861

              ---

              12,207,585

              Analgesics

              NSAR (e.g. Diclofenac 50 mg®)

              37%

              44,367

              75.6

              3,354,145

              Calcium (1000 mg) + Vit D (800 IU)

              e.g. Cal-d-Vita® (500 mg/800 IU)

              24.3%5

              29,138

              75.0

              2,185,3505

                   

              5,539,495

                  

              Total

              17,747.080

              1 Estimated proportions of Fosamax daily, once-weekly, and generic forms according to data provided by IMS.

              2 Estimated proportions of Actonel daily vs once-weekly forms according to data provided by IMS.

              3 Annual cost of treatment according to version 10 (Oct.) of the Austrian EKO (Erstattungskodex) 2008.

              4 Forsteo® + Preotact® (mean value applied).

              5 Without patients who are receiving alendronate or risedronate (calcium + vitamin D tablets already included in price).

              Nursing care and informal care

              Average number of nursing care hours per case was 83 hours for hip fracture, 14 hours for forearm fracture, 25 hours for humeral fracture, and 38 hours for clinical vertebral fracture Table 4. The total number of nursing care hours as a consequence of osteoporotic fractures was 3,232,453. Total costs of nursing care hours were estimated at € 97.0 million, thus accounting for 9.8% of overall cost. The average number of family care hours per case was 165 hours for hip fracture, 32 hours for forearm fracture, 84 hours for humeral fracture, and 81 hours for clinical vertebral fracture. The total number of family care hours was 7,536,660. Estimated total costs of (informal) family care hours were € 207.3 millions, accounting for 30.2% of overall cost.
              Table 4

              Costs of nursing care, informal care, and special aids/equipment

               

              Hip

              Forearm

              Humerus

              Clinical vertebral

              Rib1

              Costs €

               

              m

              f

              m

              f

              m

              f

              m

              f

              m

              f

               

              Nursing care

              Mean number of nursing care hours per case

              108

              58

              0

              14

              0

              25

              17

              59

              --------------------

              --------------------

              --------------------

              Total number of nursing care hours

              368,820

              664,448

              0

              261,324

              0

              186,375

              223,091

              1,528,395

              --------------------

              --------------------

              3,232,453

              Total costs (€)2

              11,064,600

              19,933,440

              0

              7,839,720

              0

              5,591,250

              6,692,730

              45,851,850

              --------------------

              --------------------

              96,973,590

              Informal (family care)

              Mean number of family care hours per case

              199

              130

              0

              32

              5

              163

              51

              111

              --------------------

              --------------------

              --------------------

              Total number of family care hours according to fracture type

              679,585

              1,489,280

              0

              597,312

              10,590

              1,215,165

              669,273

              2,875,455

              --------------------

              --------------------

              7,536,660

              Total costs (€)3

              18,688,588

              40,955,200

              0

              16,426,080

              291,225

              33,417,038

              18,405,008

              79,075,013

              --------------------

              --------------------

              207,258,151

              Special aids and equipment (crutches, wheel-chair etc.)

              Mean expenses (€) per case

              49,00

              111,67

              0,00

              5,00

              0,00

              79,59

              31,75

              69,88

              --------------------

              --------------------

              34,7

              Total expenses (€)

              167,335

              1,279,292

              0

              93,330

              0

              593,343

              416,655

              1,810,241

              --------------------

              --------------------

              4,360,196

              1 No data available from the ICUROS.

              2 Estimated cost per hour of nursing care = € 30.

              3 Estimated cost per hour of family care = € 27.50.

              Absenteeism

              Numbers and costs of absenteeism are only related to patients who have not yet retired. In 2008, 5,816 persons have been on sick leave due to osteoporotic fractures, with a mean duration of 16.3 days in men, and 18.9 days in women. In total, 100,841 sick leave days due to osteoporotic fractures have been taken (Table 5). Multiplied by the average daily income of € 128.11 this results to total costs of € 3.3 million €. The 100,841 sick leave days induced a total loss of added value of € 40.1 million, according our calculations based on the official Austrian Input–output table.
              Table 5

              Costs of absenteeism

               

              Men

              Women

              All

              Persons on sick leave due to osteoporotic fractures

              3,490

              2,326

              5,816

              Mean duration (days)

              16.3

              18.9

              17.6

              Total days

              56,887

              43,961

              100,848

              Mean gross annual income (€)

              35,325

              21,041

              28,183

              Daily income (€ year/220 working days)

              160.57

              95.65

              128.11

              Costs of absenteeism (€)

              9,134,346

              4,204,869.6

              13,339,215

              Discussion

              This study provides for the first time realistic estimates on the burden of different osteoporosis-related fractures in Austria indicating a substantial financial impact for the Austrian society in the year 2008 with a total burden of more than €685 million. With regard to direct costs, 26.6% of all costs (approx. €183 million) were spent on hospitalisation, followed by ambulatory care (13%, i.e. €93.4 million), and pharmacotherapy (12%, i.e. approx. €85 million). 34% of the total costs comprise indirect costs with estimates of informal care being the biggest part (26%, i.e. approx. €186 million). Osteoporosis is also associated with costs due to lost economic value-added which amounts to approx. €40 million.

              Although costs of osteoporotic fractures have also been estimated in other cost-of-illness studies, these estimates cannot be directly compared because of differences in resource use and patterns of care as well as different price levels of the treatment of fractures. However, these studies confirm that with respect to direct costs, the most costly fractures are hip fractures followed by vertebral fractures [2628].

              Our study, which also took into account nursing and informal care costs derived from the ICUROS data on utilisation of these resources, shows that vertebral fractures are associated with the highest proportion of these cost factors, which is in line with the results from the KOFOR study [27].

              Most published studies on costs of osteoporosis used only hospitalization rates and applied internationally accepted attribution factors [7, 10, 2832], but this approach underestimates the total burden of this disease. To minimize deficiencies inherent in under-diagnosis we not only used information drawn from the national hospital discharge register and Statistics Austria but also international data of estimations on the outpatient utilisation of resources due to osteoporotic fractures. One of the strengths of the study presented here lies in the fact that a “real world” estimation regarding the proportion of patients who would be treated after having experienced an osteoporotic fracture in Austria was applied. These estimations have been based on the findings from the ICUROS, in which it was clearly demonstrated that in Austria, irrespective of innumerable awareness programmes that have been performed in the past, only about 22% of those who experience an osteoporotic fracture would receive an adequate pharmacological treatment.

              There are, however, several methodological issues to be considered in interpreting the results of our study. Although it is mandatory for all hospitals in Austria to record discharge diagnoses by using the code classes of the International Classification of Diseases (ICD-10), it is possible that patients have multiple registrations for the same diagnosis. Based on this, Dimai et al. used a correction factor of 0.9 to adjust the incidence calculations for hip fractures in Austria [13]. Since there is no information available on age group specific correction factors for other types of fracture than hip, no correction factor was used for these types of fracture.

              Another limitation of our study may be the method used to estimate those fractures, which are only partially treated in hospitals. For instance, it has been estimated that only one in three of those who experience a vertebral fracture will come to medical attention [33]. From these, as shown in a Swedish study, only approximately 10% would be hospitalized [16]. Furthermore, treatment of distal forearm fractures is highly variable in different centres in Austria. While some prefer surgical treatment others prefer casting, which is done on an outpatient basis. Likewise, high geographical variations have been noted in international studies on the prevalence of different osteoporotic fractures. With this in mind, our multiplication factors, which were taken according to results from several other national studies, may actually either over- or underestimate the total rates of the different fractures due to osteoporosis in Austria.

              Unfortunately, our study has not been designed to include costs for rehab. However, we believe that this limitation of our study would not impose a significant bias, since e.g. in Germany only 4% of total expenses are incurred by rehabilitation costs [12].

              In contrast to the high expenditures, significant progress in the treatment and prevention of osteoporosis has been achieved in the past two decades with the development of different compounds with a proven effect on bone mineral density and reduction of fracture risk [3436].

              Despite of this, approximately 50% of patients do not follow their prescribed treatment regimen and/or discontinue treatment within one year [37]. Poor compliance is not only associated with higher fracture rates but also increased morbidity, mortality, and costs [38, 39]. Likewise, a German study has shown that only 22% of osteoporotic patients have received treatment; and moreover, 58% (daily dosing) and 43% (weekly dosing) of these patients terminate their treatment [12]. Even though these medications are only indicated in patients with a fracture risk of more than 30%, these numbers reflect a high degree of unawareness and under-treatment of osteoporosis. This has also been shown in a recent Austrian study in nursing homes and senior’s residences, where more than 20% of the patients had a diagnosis of osteoporosis, but only 7.2% of them were prescribed specific treatment [40].

              Conclusions

              The results of our cost-of-illness study show that osteoporosis is a costly disease with a significant financial burden to the Austrian society. To improve the awareness of osteoporosis being not only an economic problem, but also a determinant of quality of life in patients affected, appropriate public health strategies need to be applied. In this regard, the substantial socio-economic burden resulting from osteoporotic fractures underlines the importance of pharmacological treatment in those who are at risk of osteoporosis, to prevent first and subsequent fractures.

              Declarations

              Authors’ Affiliations

              (1)
              Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz
              (2)
              Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna
              (3)
              Association for the Promotion of Continuing Medical Education and Research
              (4)
              I3 Innovus
              (5)
              Medical Management Centre, Karolinska Institutet
              (6)
              Department for Public Health and Health Technology Assessment, UMIT–University for Health Sciences. Medical Informatics and Technology
              (7)
              Department of Economics, Faculty of Business, Economics and Statistics, University of Vienna

              References

              1. Consensus development conference: prophylaxis and treatment of osteoporosis Am J Med 1991,90(1):107–10.
              2. Johnell O, Kanis J: Epidemiology of osteoporotic fractures. Osteoporos Int 2005,16(2):S3–7. 10.1007/s00198-004-1702-6PubMedView Article
              3. Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, et al.: Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 2011,22(5):1277–88. 10.1007/s00198-011-1601-6PubMed CentralPubMedView Article
              4. Johnell O, Kanis JA: An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006,17(12):1726–33. 10.1007/s00198-006-0172-4PubMedView Article
              5. Cummings SR, Melton LJ: Epidemiology and outcomes of osteoporotic fractures. Lancet 2002,359(9319):1761–7. 10.1016/S0140-6736(02)08657-9PubMedView Article
              6. Ben Sedrine W, Radican L, Reginster JY: On conducting burden-of-osteoporosis studies: a review of the core concepts and practical issues. A study carried out under the auspices of a WHO Collaborating Center. Rheumatology (Oxford) 2001,40(1):7–14. 10.1093/rheumatology/40.1.7View Article
              7. Lippuner K, Golder M, Greiner R: Epidemiology and direct medical costs of osteoporotic fractures in men and women in Switzerland. Osteoporos Int 2005,16(Suppl 2):S8–17.PubMedView Article
              8. Gabriel SE, Tosteson ANA, Leibson CL, Crowson CS, Pond GR, Hammond CS, et al.: Direct medical costs attributable to osteoporotic fractures. Osteoporos Int 2002,13(4):323–30. 10.1007/s001980200033PubMedView Article
              9. Wiktorowicz ME, Goeree R, Papaioannou A, Adachi JD, Papadimitropoulos E: Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int 2001,12(4):271–8. 10.1007/s001980170116PubMedView Article
              10. Reginster JY, Gillet P, Ben Sedrine W, Brands G, Ethgen O, de Froidmont C, et al.: Direct costs of hip fractures in patients over 60 years of age in Belgium. Pharmacoeconomics 1999,15(5):507–14. 10.2165/00019053-199915050-00008PubMedView Article
              11. Brecht J, Schdlich P: Burden of illness imposed by osteoporosis in Germany. HEPAC Health Economics in Prevention and Care 2000,1(1):26. 10.1007/s101980050006View Article
              12. Häussler B, Gothe H, Göl D, Glaeske G, Pientka L, Felsenberg D: Epidemiology, treatment and costs of osteoporosis in Germany–the BoneEVA Study. Osteoporos Int 2007,18(1):77–84. 10.1007/s00198-006-0206-yPubMedView Article
              13. Dimai HP, Svedbom A, Fahrleitner-Pammer A, Pieber T, Resch H, Zwettler E, et al.: Epidemiology of hip fractures in Austria: evidence for a change in the secular trend. Osteoporos Int 2011,22(2):685–92. 10.1007/s00198-010-1271-9PubMedView Article
              14. Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL: Methods for the Economic Evaluation of Health Care Programs. 3rd edition. Oxford University Press, Oxford; 2005.
              15. Johannesson M, Karlsson G: The friction cost method: a comment. J Health Econ 1997,16(2):249–55. 10.1016/S0167-6296(97)00006-4PubMedView Article
              16. Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B: Excess mortality after hospitalisation for vertebral fracture. Osteoporos Int 2004,15(2):108–12. 10.1007/s00198-003-1516-yPubMedView Article
              17. Garraway WM, Stauffer RN, Kurland LT, O'Fallon WM: Limb fractures in a defined population.II. Orthopedic treatment and utilization of health care. Mayo Clin Proc 1979,54(11):708–13.PubMed
              18. Arden N, Cooper Meunier P, future of osteoporosis: Epidemiology. Osteoporosis 1998.
              19. Neill D, Hughes D, Leake A, Morris C, Jones D, Oakley A, et al.: Neuritogenic-neurotoxic effects of membrane-associated forms of amyloid precursor protein. Dement Geriatr Cogn Disord 2001,12(1):40–51. 10.1159/000051234PubMedView Article
              20. Palvanen M, Kannus P, Niemi S, Parkkari J: Hospital-treated minimal-trauma rib fractures in elderly Finns: long-term trends and projections for the future. Osteoporos Int 2004,15(8):649–53.PubMedView Article
              21. Palvanen M, Kannus P, Niemi S, Parkkari J, Vuori I: Epidemiology of minimal trauma rib fractures in the elderly. Calcif Tissue Int 1998,62(3):274–7. 10.1007/s002239900429PubMedView Article
              22. Erstattungskodex-EKO. 1030th edition. Hauptverband der österreichischen Sozialversicherungsträger, Wien; 2008.
              23. Statistik Austria: Arbeitskostenerhebungen 2008. Statistik Austria; 2008.
              24. Miller RE, Blair PB: Input–output Analysis. Foundations and Extentions. Cambridge University Press, New York; 2010.
              25. Obermayer U, Mayer-Schulz M, Stefanits J: Invaliditätspensionen. In Sozialbericht 2007 – 2008 - Ressortaktivitäten und sozialpolitische Analysen. Bundesministerium für Soziales und Konsumentenschutz, Vienna; 2008.
              26. Borgström F, Sobocki P, Ström O, Jönsson B: The societal burden of osteoporosis in Sweden. Bone 2007,40(6):1602–9. 10.1016/j.bone.2007.02.027PubMedView Article
              27. Borgström F, Zethraeus N, Johnell O, Lidgren L, Ponzer S, Svensson O, et al.: Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporos Int 2006,17(5):637–50. 10.1007/s00198-005-0015-8PubMedView Article
              28. Pike MM, Barnes MA, Barron RW: The role of illustrations in children's inferential comprehension. J Exp Child Psychol 2010,105(3):243–55. 10.1016/j.jecp.2009.10.006PubMedView Article
              29. Bouza C, López T, Palma M, Amate JM: Hospitalised osteoporotic vertebral fractures in Spain: analysis of the national hospital discharge registry. Osteoporos Int 2007,18(5):649–57. 10.1007/s00198-006-0292-xPubMedView Article
              30. Zethraeus N, Strömberg L, Jönsson B, Svensson O, Ohlén G: The cost of a hip fracture. Estimates for 1,709 patients in Sweden. Acta Orthop Scand 1997,68(1):13–7. 10.3109/17453679709003968PubMedView Article
              31. Johnell O, Gullberg B, Kanis JA: The hospital burden of vertebral fracture in Europe: a study of national register sources. Osteoporos Int 1997,7(2):138–44. 10.1007/BF01623689PubMedView Article
              32. Johnell O, Kanis JA, Jonsson B, Oden A, Johansson H, De Laet C: The burden of hospitalised fractures in Sweden. Osteoporos Int 2005,16(2):222–8. 10.1007/s00198-004-1686-2PubMedView Article
              33. Cooper C, Campion G, Melton LJ: Hip fractures in the elderly: a world-wide projection. Osteoporos Int 1992,2(6):285–9. 10.1007/BF01623184PubMedView Article
              34. Riggs BL, Hartmann LC: Selective estrogen-receptor modulators – mechanisms of action and application to clinical practice. N Engl J Med 2003,348(7):618–29. 10.1056/NEJMra022219PubMedView Article
              35. Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, et al.: Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 2009,361(8):756–65. 10.1056/NEJMoa0809493PubMedView Article
              36. Dimai HP, Pietschmann P, Resch H, Preisinger E, Fahrleitner-Pammer A, Dobnig H, et al.: Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women–update 2009. Wien Med Wochenschr Suppl 2009, 122: 1–34.PubMedView Article
              37. Seeman E, Compston J, Adachi J, Brandi ML, Cooper C, Dawson-Hughes B, et al.: Non-compliance: the Achilles' heel of anti-fracture efficacy. Osteoporos Int 2007,18(6):711–9. 10.1007/s00198-006-0294-8PubMedView Article
              38. Silverman SL, Gold DT, Cramer JA: Reduced fracture rates observed only in patients with proper persistence and compliance with bisphosphonate therapies. South Med J 2007,100(12):1214–8. 10.1097/SMJ.0b013e31815a9685PubMedView Article
              39. Reginster J: Adherence and persistence: impact on outcomes and health care resources. Bone 2006,38(2 Suppl 2):S18–21.PubMedView Article
              40. Pietschmann P, Azizi-Semrad U, Pils K, Fahrleitner-Pammer A, Resch H, Dobnig H: Pharmacologic undertreatment of osteoporosis in Austrian nursing homes and senior's residences. Wien Klin Wochenschr 2010,122(17–18):532–7.PubMedView Article

              Copyright

              © Dimai et al.; licensee Springer. 2012

              This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.